Biontech announces establishment of interdisciplinary mrna excellence center to conduct research jointly with scientists from weizmann institute of science in israel

Jerusalem, israel, march 1, 2023 – biontech se (nasdaq: bntx, “biontech”, “the company”) announced that the company and the weizmann institute of science (“weizmann institute”) signed a memorandum of understanding (mou). as part of this mou, scientists from a variety of disciplines from biontech and the weizmann institute will collaborate in basic and applied research with the aim to better understand various diseases, including cancer, infectious diseases, and neurodegenerative diseases. the joint research will be conducted at biontech's newly established mrna excellence center and in weizmann institute laboratories.
BNTX Ratings Summary
BNTX Quant Ranking